Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bunjes

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
European Journal of Haematology|September 1, 1988
T-cell depletion versus methotrexate as GvHD-prophylaxis in allogeneic bone marrow transplantation for leukaemiaM Wiesneth, B Hertenstein, D Bunjes, et al.
Infection|May 1, 1989
Infectious complications after allogeneic bone marrow transplantation with and without T-cell depletion of donor marrowT Schmeiser, M Wiesneth, D Bunjes, et al.
Bone Marrow Transplantation|May 1, 1995
Successful therapy with donor buffy coat transfusions in patients with relapsed chronic myeloid leukemia after bone marrow transplantation is associated with high frequencies of host-reactive interleukin 2-secreting T helper cellsD Bunjes, M Theobald, B Hertenstein, et al.
Journal of Hematotherapy|July 23, 1999
Comparison of T-cell-depleted BMT and PBPCT with respect to chimerism, graft rejection, and leukemic relapseM Wiesneth, T Schreiner, D Bunjes, et al.
Bone Marrow Transplantation|April 1, 1996
Antibodies to interferon-alpha: a novel type of autoantibody occurring after allogeneic bone marrow transplantationO Prümmer, D Bunjes, M Wiesneth, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 2, 2003
Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonographyP Gottlöber, U Leiter, W Friedrich, et al.
Bone Marrow Transplantation|October 19, 2001
Fatal outcome in a patient developing Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD) without measurable diseaseM Ringhoffer, K Döhner, S Scheil, et al.
International Journal of Hematology|July 1, 1994
CD 54 expression and its role in homotypic aggregation of the blasts of acute myeloblastic leukemias (AML)G Heil, J Krauter, E Beyer-Johannböke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic LeukemiaA Osterborg, M J Dyer, D Bunjes, et al.
Bone Marrow Transplantation|January 1, 1993
In vitro and in vivo depletion of T cellsR Arnold, D Bunjes, M Wiesneth, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
European Journal of Haematology|September 1, 1988
T-cell depletion versus methotrexate as GvHD-prophylaxis in allogeneic bone marrow transplantation for leukaemiaM Wiesneth, B Hertenstein, D Bunjes, et al.
Infection|May 1, 1989
Infectious complications after allogeneic bone marrow transplantation with and without T-cell depletion of donor marrowT Schmeiser, M Wiesneth, D Bunjes, et al.
Bone Marrow Transplantation|May 1, 1995
Successful therapy with donor buffy coat transfusions in patients with relapsed chronic myeloid leukemia after bone marrow transplantation is associated with high frequencies of host-reactive interleukin 2-secreting T helper cellsD Bunjes, M Theobald, B Hertenstein, et al.
Journal of Hematotherapy|July 23, 1999
Comparison of T-cell-depleted BMT and PBPCT with respect to chimerism, graft rejection, and leukemic relapseM Wiesneth, T Schreiner, D Bunjes, et al.
Bone Marrow Transplantation|April 1, 1996
Antibodies to interferon-alpha: a novel type of autoantibody occurring after allogeneic bone marrow transplantationO Prümmer, D Bunjes, M Wiesneth, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 2, 2003
Chronic cutaneous sclerodermoid graft-versus-host disease: evaluation by 20-MHz sonographyP Gottlöber, U Leiter, W Friedrich, et al.
Bone Marrow Transplantation|October 19, 2001
Fatal outcome in a patient developing Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD) without measurable diseaseM Ringhoffer, K Döhner, S Scheil, et al.
International Journal of Hematology|July 1, 1994
CD 54 expression and its role in homotypic aggregation of the blasts of acute myeloblastic leukemias (AML)G Heil, J Krauter, E Beyer-Johannböke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic LeukemiaA Osterborg, M J Dyer, D Bunjes, et al.
Bone Marrow Transplantation|January 1, 1993
In vitro and in vivo depletion of T cellsR Arnold, D Bunjes, M Wiesneth, et al.
Pageof 11